Skip to main content
Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
43.31
+0.42 (0.98%)
At close: Nov 13, 2026, 4:00 PM EST
43.12
-0.19 (-0.44%)
After-hours: Nov 13, 2026, 7:30 PM EST

Spruce Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--4.9110.09--
Revenue Growth
---51.32%---
Cost of Revenue
45.2813.6246.4249.4335.2-
Gross Profit
-45.28-13.62-41.51-39.34-35.2-
Selling, General & Admin
19.6114.9914.6412.6512.0911.37
Research & Development
-----30.7
Operating Expenses
19.6114.9914.6412.6512.0942.07
Operating Income
-64.88-28.61-56.15-51.99-47.28-42.07
Interest Expense
-2.98-0.09-0.31-0.48-0.42-0.35
Interest & Investment Income
2.551.143.424.561.520.12
Other Non Operating Income (Expenses)
-3.14-3.5----
EBT Excluding Unusual Items
-68.45-31.07-53.04-47.92-46.18-42.29
Merger & Restructuring Charges
2.6-0.9----
Legal Settlements
-1.9-1.9----
Other Unusual Items
0.6-5.1----
Pretax Income
-67.15-38.97-53.04-47.92-46.18-42.29
Net Income
-67.15-38.97-53.04-47.92-46.18-42.29
Net Income to Common
-67.15-38.97-53.04-47.92-46.18-42.29
Net Income Growth
------
Shares Outstanding (Basic)
211100
Shares Outstanding (Diluted)
211100
Shares Change
242.02%39.34%7.14%63.68%0.71%289.93%
EPS (Basic)
-33.82-50.83-96.40-93.32-147.21-135.78
EPS (Diluted)
-33.82-50.83-96.40-93.32-147.21-135.78
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-51.21-33.33-55.96-33.28-41.69-35.97
Free Cash Flow Per Share
-25.80-43.47-101.73-64.82-132.90-115.48
Operating Margin
---1143.37%-515.34%--
Profit Margin
---1079.94%-474.96%--
Free Cash Flow Margin
---1139.56%-329.88%--
EBITDA
-63.25-28.59-56.11-51.92-47.21-42
D&A For EBITDA
1.630.020.050.070.070.07
EBIT
-64.88-28.61-56.15-51.99-47.28-42.07